| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Neurology Devices Market Size 2024 |
USD 16,150 million |
| Neurology Devices Market, CAGR |
8.7% |
| Neurology Devices Market Size 2032 |
USD 31,478.12 million |
Market Overview:
The Neurology Devices market is projected to grow from USD 16,150 million in 2024 to USD 31,478.12 million by 2032, with a compound annual growth rate (CAGR) of 8.7%.
The neurology devices market is driven by the rising prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, and epilepsy, coupled with the increasing geriatric population worldwide. Advances in neuroimaging techniques and minimally invasive neurosurgeries are boosting demand for innovative devices that offer higher accuracy and improved patient outcomes. The growing adoption of wearable neurostimulation devices for pain management and rehabilitation also contributes to market growth. Moreover, increased government funding for neuroscience research and the development of technologically advanced products by key industry players are further fueling the expansion of this market. Key trends include the integration of artificial intelligence and robotics in neurology devices, the growing focus on personalized medicine, and the increasing availability of portable and home-use devices. These factors are expected to enhance patient care while reducing healthcare costs, positioning the neurology devices market for continued growth over the coming years.
The neurology devices market exhibits significant geographical variations, with North America leading, accounting for approximately 40% of the market in 2024, driven by the U.S.’s advanced healthcare infrastructure and high adoption of innovative devices. Europe, holding around 25%, benefits from an aging population and government support for neurological research. Asia-Pacific, projected to capture 20% of the market, is the fastest-growing region due to rising healthcare investments and increasing awareness of neurological treatments in countries like China, Japan, and India. Latin America, the Middle East, and Africa, with around 15% market share, are gradually expanding, supported by improving healthcare systems. Key players such as Medtronic, Johnson & Johnson Services Inc., Stryker, and Abbott maintain strong global presences, driving market growth across these regions.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
Download Sample
Market Insights:
- The neurology devices market is projected to grow from USD 16,150 million in 2024 to USD 31,478.12 million by 2032, with a CAGR of 8.7%.
- Rising prevalence of neurological disorders like Alzheimer’s, Parkinson’s, and epilepsy, along with an aging global population, is a key market driver.
- Advances in neuroimaging techniques, minimally invasive neurosurgeries, and the growing demand for wearable neurostimulation devices are boosting market growth.
- Government funding for neuroscience research and development of technologically advanced products is further driving market expansion.
- Integration of artificial intelligence and robotics in neurology devices is a key trend, enabling real-time data analysis and personalized medicine.
- North America is expected to lead with 40% market share in 2024, followed by Europe at 25%, and Asia-Pacific as the fastest-growing region with 20%.
- Key players like Medtronic, Abbott, Johnson & Johnson Services Inc., and Stryker are driving innovation and market growth across all regions.
Market Drivers:
Increasing Prevalence of Neurological Disorders:
The rising incidence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis is a major driver for the neurology devices market. As the global population ages, the prevalence of age-related neurological conditions is increasing, leading to a growing demand for diagnostic and therapeutic devices. Early detection and improved management of these conditions are critical, further driving the need for advanced neurology devices.
Technological Advancements in Neurology Devices:
Technological innovations in neuroimaging, neuromodulation, and neurostimulation devices are propelling the growth of the neurology devices market. For instance, Apollo Hospitals has introduced the ZAP-X gyroscopic radiosurgery platform, which delivers radiation to brain tumors with 95% tumor control rates over ten years. The development of minimally invasive surgical techniques and devices that offer greater precision and enhanced patient outcomes is significantly contributing to market expansion. Furthermore, the integration of artificial intelligence (AI) and robotics into neurology devices has enabled real-time data analysis and more effective treatment options, boosting adoption rates.
Growing Demand for Wearable and Home-Use Devices:
The increasing shift towards patient-centric care has led to the rising adoption of wearable and home-use neurology devices. These devices provide continuous monitoring and treatment for patients with neurological conditions, improving patient convenience and reducing hospital visits. The growing popularity of wearable neurostimulation devices for pain management and rehabilitation has also contributed to the overall growth of the market, as patients seek more accessible and non-invasive treatment options.
Government Support and Rising Healthcare Expenditure:
Government initiatives and increased funding for neuroscience research are further fueling the expansion of the neurology devices market. Public health agencies and private organizations are investing in research and development of innovative devices to address the growing burden of neurological disorders. For instance, the National Institutes of Health (NIH) BRAIN Initiative has been actively supporting the development of innovative neurotechnologies, including clinical prototype devices and non-invasive brain stimulation tools, through milestone-driven funding programs aimed at advancing treatment for neurological disorders. Additionally, rising healthcare expenditure, particularly in emerging economies, is enabling greater access to neurology devices, thus driving market growth globally.
Market Trends:
Integration of Artificial Intelligence and Robotics:
The integration of artificial intelligence (AI) and robotics in neurology devices is one of the most prominent trends in the market. AI-powered algorithms are being used to enhance diagnostic accuracy, analyze complex neurological data, and predict patient outcomes. Robotics is increasingly being utilized in neurosurgeries, offering greater precision and control during delicate procedures. This convergence of AI and robotics is transforming neurology practices by improving patient outcomes and reducing recovery times.
Rise of Minimally Invasive Procedures:
There is a growing preference for minimally invasive neurosurgical procedures, which is driving demand for advanced neurology devices. These procedures reduce patient risk, shorten hospital stays, and lead to faster recovery times compared to traditional surgeries. For instance, Abbott’s Proclaim Plus Spinal Cord Stimulation system provides tailored pain relief across multiple body areas using FlexBurst360 therapy. Devices such as neuromodulation and neuroendoscopy systems are gaining traction, as they enable clinicians to perform precise interventions with minimal tissue damage, enhancing patient safety and procedural efficiency.
Expansion of Wearable and Portable Devices:
The increasing demand for wearable and portable neurology devices is a key trend shaping the market. These devices offer continuous monitoring and treatment outside of clinical settings, improving patient adherence to therapies and enabling remote management of neurological conditions. Wearable neurostimulation devices for pain management and rehabilitation, in particular, are becoming more popular, providing patients with non-invasive and convenient treatment options that can be used at home.
Personalized Neurological Care:
The shift towards personalized medicine is influencing the neurology devices market, with a focus on individualized treatment plans based on patient-specific data. Neurology devices are increasingly being designed to cater to the unique needs of patients, optimizing treatment efficacy. For instance, Sinaptica’s personalized neuromodulation therapy for Alzheimer’s disease demonstrated a 44% slowing of disease progression over 12 months in a Phase 2 study, using rTMS-EEG based personalization to target the Default Mode Network. Personalized neurostimulation therapies and tailored neurodiagnostic solutions are gaining traction, as they enable more effective management of neurological disorders and improve long-term patient outcomes.
Market Challenges Analysis:
High Costs and Limited Accessibility:
One of the significant challenges facing the neurology devices market is the high cost of advanced devices and treatments, which can limit accessibility, especially in developing regions. Neurology devices such as neurostimulation systems, robotic-assisted surgical tools, and advanced neuroimaging equipment involve substantial capital investment. This makes them less affordable for smaller healthcare facilities and restricts their availability in low- and middle-income countries. As a result, many patients in these regions are unable to benefit from the latest advancements in neurological care. Moreover, the cost burden on healthcare providers and patients, especially in the absence of comprehensive insurance coverage, further impedes the widespread adoption of these devices. For instance, according to a 2023 report by the Indian Ministry of Health and Family Welfare, only 1 in 10 hospitals in India have access to advanced neuroimaging equipment. Addressing this challenge requires collaborative efforts from governments, healthcare institutions, and manufacturers to reduce costs and enhance affordability through subsidies, partnerships, and innovative financing models.
Regulatory Hurdles and Reimbursement Issues:
The neurology devices market also faces regulatory and reimbursement challenges that affect product development and market entry. Regulatory bodies impose stringent approval processes for neurology devices to ensure safety and efficacy, which can delay the launch of new products. The complexity of obtaining approvals for devices involving cutting-edge technologies like artificial intelligence and robotics adds to this challenge. Furthermore, reimbursement policies for neurology devices vary across regions and healthcare systems, with many devices not covered under insurance plans. The lack of clear and consistent reimbursement frameworks discourages healthcare providers from adopting these devices, limiting their market penetration. To overcome these regulatory and reimbursement barriers, manufacturers need to engage with regulatory authorities early in the development process and work closely with policymakers to establish clearer guidelines and favorable reimbursement policies. Addressing these issues will be crucial in driving the adoption and market growth of neurology devices.
Market Opportunities:
The neurology devices market offers significant growth opportunities driven by the rising global demand for advanced neurological care. The increasing prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, and epilepsy presents an untapped market, particularly in emerging economies where access to advanced medical technologies is still limited. Expanding into these regions by offering cost-effective solutions and portable devices can provide manufacturers with a competitive edge. Additionally, the aging population, especially in developed nations, is driving the demand for neurology devices, creating opportunities for companies to develop products specifically tailored to geriatric care. The growing emphasis on early diagnosis and intervention also opens doors for innovative neurodiagnostic devices that can detect conditions at earlier stages, leading to better patient outcomes.
Another promising opportunity lies in the development of AI-integrated and minimally invasive devices that cater to the rising demand for personalized and patient-centric care. As healthcare systems worldwide shift towards value-based care, there is a growing need for neurology devices that offer improved clinical outcomes while reducing healthcare costs. Companies that invest in the development of AI-powered neurology devices, robotic-assisted technologies, and wearable solutions stand to benefit from this trend. Moreover, increasing partnerships between technology firms and healthcare providers to enhance device innovation and distribution can further unlock growth potential in this market. By focusing on these areas, companies can capture new revenue streams and expand their market presence globally.
Market Segmentation Analysis:
By Product:
The neurology devices market is segmented by product into neurostimulation devices, neurointerventional devices, neurosurgical devices, and neurodiagnostic devices. Neurostimulation devices hold a significant market share due to their widespread use in treating chronic pain, epilepsy, and movement disorders. Neurodiagnostic devices are also growing rapidly, driven by advances in neuroimaging technologies for early diagnosis.
By End User:
The market is further segmented by end user into hospitals, specialty clinics, and ambulatory surgical centers. Hospitals dominate the market, as they are the primary centers for complex neurological treatments and surgeries. However, specialty clinics and ambulatory surgical centers are gaining traction due to their growing capabilities in offering minimally invasive procedures, shorter recovery times, and outpatient care, providing convenient alternatives to traditional hospital care.
Segments:
Based on Product
- Neurostimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electric Stimulation
- Interventional Neurology
- Aneurysm Coiling and Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Reagents
- Neurovascular Catheters
- Microcatheters
- Microguidewires
- Cerebral Balloon Angioplasty & Stents
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothromobectomy
- Clot Retrievers
- Suction Aspiration Devices
- Snare Devices
- CSF Management Devices
- Cerebral Shunts
- Cerebral External Drainage
- Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips
Based on End User
- Hospitals & Clinics
- Specialty Center
Based on the Geography:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis:
North America:
North America is expected to hold the largest market share in the neurology devices market, accounting for 40% in 2024. The region’s dominance is driven by several factors, including the rising prevalence of neurological disorders such as Alzheimer’s and Parkinson’s disease, along with the strong presence of key market players. The U.S., in particular, leads the region due to its advanced healthcare infrastructure, high healthcare spending, and increased adoption of technologically advanced neurology devices. Additionally, favorable reimbursement policies and significant investments in neurological research further bolster the market in North America. The growing demand for minimally invasive neurosurgeries and wearable neurostimulation devices is also contributing to the market’s growth in this region.
Europe:
Europe is anticipated to hold 25% of the neurology devices market share in 2024, making it the second-largest market. The increasing aging population, particularly in countries like Germany, France, and the UK, is a key driver of market growth, as older adults are more susceptible to neurological disorders. Additionally, government support for research and development in neuroscience, coupled with the availability of advanced healthcare systems, is fueling the demand for neurology devices across the region. The rise in minimally invasive surgical procedures and early diagnosis technologies is also contributing to the expansion of the market in Europe. Regulatory bodies in the region are ensuring the safety and efficacy of neurology devices, fostering greater trust and adoption among healthcare providers.
Asia-Pacific
Asia-Pacific is expected to witness the fastest growth in the neurology devices market, with a projected market share of 20% in 2024. The rapid growth is attributed to the rising incidence of neurological disorders, increasing healthcare investments, and improving healthcare infrastructure in countries such as China, India, and Japan. The growing awareness of early diagnosis and treatment, coupled with the increasing availability of advanced neurology devices, is driving market demand in the region. Additionally, the large aging population and the increasing prevalence of lifestyle-related neurological disorders like stroke and dementia are creating significant growth opportunities for manufacturers. The region’s expanding medical tourism industry is also contributing to the market’s growth, as more patients seek affordable neurological treatments.
Latin America, Middle East, and Africa:
Latin America, the Middle East, and Africa are expected to hold a smaller market share, accounting for 15% in 2024. In these regions, the neurology devices market is gradually expanding due to improving healthcare infrastructure, rising awareness of neurological disorders, and increasing government initiatives to enhance healthcare services. Brazil and Mexico in Latin America are leading markets, while the Middle East and Africa are experiencing steady growth, supported by growing investments in healthcare technologies. However, challenges such as limited access to advanced healthcare facilities and high device costs remain barriers to widespread adoption in these regions.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis:
- Abbott
- Axonics, Inc.
- Microport Scientific Corporation
- Codman Neuro (Integra Lifesciences)
- LivaNova PLC
- Microvention Inc (Terumo Corporation)
- Penumbra, Inc.
- electroCore, Inc.
- Stryker
- Johnson and Johnson Services Inc.
- Neuropace Inc.
- Boston Scientific Corporation
- Medtronic
- Nexstim
Competitive Analysis:
The neurology devices market is highly competitive, with leading players such as Medtronic, Johnson & Johnson Services Inc., Penumbra, Inc., Microport Scientific Corporation, Stryker, Microvention Inc. (Terumo Corporation), Codman Neuro (Integra Lifesciences), Abbott, Boston Scientific Corporation, Nexstim, LivaNova PLC, Neuropace Inc., electroCore, Inc., and Axonics, Inc. These companies compete based on product innovation, technological advancements, and strategic collaborations. Medtronic and Abbott hold strong positions due to their extensive portfolios and global reach in neurostimulation devices. Johnson & Johnson and Stryker lead in neurointerventional and neurosurgical devices, benefiting from a robust presence in the surgical segment. Penumbra and Microvention are making strides in neurovascular devices, focusing on minimally invasive solutions. Companies like Axonics and Neuropace are gaining traction with innovative neuromodulation devices aimed at specific neurological disorders. Overall, continuous innovation, R&D investments, and market expansions are key strategies employed by these companies to maintain competitive advantage.
Recent Developments:
- In August 2024, AbbVie completed the acquisition of Cerevel Therapeutics for USD 8.7 billion. This agreement grants AbbVie access to several clinical-stage and preclinical candidates aimed at treating neurological and psychiatric disorders. The acquisition is expected to enhance AbbVie’s research and development efforts in neuroscience, advancing its mission to create innovative therapies for patients with serious and complex conditions.
- In July 2024, Mainstay Medical Holdings plc received regulatory approvals in the European Union, the UK, and Australia for full-body MRI conditional labeling of the ReActiv8 Restorative Neurostimulation system. This allows all current and future ReActiv8 patients in Europe and Australia with commercially available 45 cm leads to safely undergo 1.5T full-body MRI scans.
- In January 2024, Oragenics acquired neurological assets from Odyssey Health, including the primary concussion treatment asset ONP-002 and a unique nasal delivery device. These assets are expected to significantly expand Oragenics’ market potential.
- In February 2025, Medtronic has received U.S. FDA approval for the world’s first Adaptive Deep Brain Stimulation (DBS) system for individuals with Parkinson’s disease. This technology uses real-time brain signals to adjust stimulation levels based on the patient’s needs, offering a more personalized and responsive treatment approach.
Market Concentration & Characteristics:
The neurology devices market is moderately concentrated, with a few key players dominating a significant portion of the global market. Companies like Medtronic, Johnson & Johnson Services Inc., Stryker, and Abbott lead the market due to their extensive product portfolios, strong R&D capabilities, and global distribution networks. These firms consistently invest in innovation, focusing on developing technologically advanced and minimally invasive devices that meet the rising demand for improved patient outcomes. The market is characterized by high barriers to entry due to the stringent regulatory approval processes, high development costs, and the need for specialized expertise in neurology. Smaller players and new entrants often focus on niche segments or collaborate with established companies to gain market traction. Additionally, the increasing integration of artificial intelligence and robotics is shaping the competitive landscape, driving differentiation and creating growth opportunities for both established and emerging players.
Report Coverage:
The research report offers an in-depth analysis based on Product, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- The neurology devices market is expected to continue its growth trajectory, driven by increasing neurological disorder cases worldwide.
- Advancements in neurostimulation and neurodiagnostic devices will play a pivotal role in shaping future market demand.
- Artificial intelligence integration in neurology devices is likely to enhance diagnosis accuracy and treatment personalization.
- The demand for minimally invasive neurosurgeries is expected to rise, promoting innovation in surgical devices.
- Wearable and home-use neurology devices will see greater adoption as patient-centric care gains momentum.
- Emerging markets, particularly in Asia-Pacific, will drive significant growth due to improving healthcare infrastructure.
- Aging populations globally will increase the demand for devices targeting age-related neurological conditions.
- Government funding for neuroscience research will continue to support product innovation and development.
- Regulatory challenges and reimbursement issues will remain key concerns for manufacturers entering new markets.
- Collaboration between technology firms and healthcare providers will foster product advancements and market expansion.
